Genes identified included novel genes such as HPGD, FASN and KRT81, as well as SCIN and TPM1 which have already been confirmed in acquired drug resistance mechanisms associated with HER2-positive breast cancer (Fig. 3e). This evidence concerns the gene ERBB2 and breast cancer.